MMP-12 (catalytic domain), (human) (recombinant) | Enzo Life Sciences BML-SE138-0010 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Enzo Life Sciences

other brands :

Stressgen, BioMol, Alexis Corporation, Assay Designs, Alexis

product type :

protein

product name :

MMP-12 (catalytic domain), (human) (recombinant)

catalog :

BML-SE138-0010

quantity :

10 µg

citations: 3

Reference
Iyer R, Patterson N, Zouein F, Ma Y, Dive V, de Castro BrÃ¡s L, et al. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution. Int J Cardiol. 2015;185:198-208 pubmed publisher
Brezski R, Oberholtzer A, Strake B, Jordan R. The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge. MAbs. 2011;3:558-67 pubmed publisher
Taddese S, Jung M, Ihling C, Heinz A, Neubert R, Schmelzer C. MMP-12 catalytic domain recognizes and cleaves at multiple sites in human skin collagen type I and type III. Biochim Biophys Acta. 2010;1804:731-9 pubmed publisher

product information

Product ID :

BML-SE138

Catalog Number :

BML-SE138-0010

Product Name :

MMP-12 (catalytic domain), (human) (recombinant)

Product Type :

Protein

Size :

10 µg

list of Pubmed id :

25797678, 22123056, 19932771

ALTnames :

Matrix metalloproteinase 12, Metalloelastase, Macrophage elastase

Purity :

≥95% (SDS-PAGE)

Buffer :

Liquid. In 50mM TRIS, pH 9.5, containing 5mM calcium chloride, 500mM sodium chloride, 20µM zinc chloride, 0.5% Brij-35, and 30% glycerol.

Uses :

Useful tool to study enzyme kinetics, cleave target substrates, and screen for inhibitors.

Storage :

-80°C